143 Results for "

CRC

" in MedChemExpress (MCE) Product Catalog:
Products (143)

143 Results for "CRC" in MCE Product Catalog:

7
7 Publications Verification
Art. -Nr.: HY-B0294
CAS. Nr.: 31430-15-6
Flubendazole is an anthelmintic drug based on altering microtubule structure, inhibition of tubulin polymerization and disruption of microtubule function. Flubendazole induces apoptosis in human colorectal cancer (CRC) by blocking the STAT3 signaling axis and activation of autophagy. Flubendazole induces P53 expression and reduced Cyclin B1 and p-cdc2 expression. Flubendazole is an antitumor agent. Flubendazole can be used for worm and intestinal parasites .
loading...
    loading...
7
7 Publications Verification
Art. -Nr.: HY-136173
CAS. Nr.: 1801765-04-7
Reinheit:  99.41%
Synonyms: TNO155
Target:  

SHP2 Phosphatase

Forschungsgebiete:  

Cancer

Batoprotafib (TNO155) is a potent selective and orally active allosteric inhibitor of wild-type SHP2 (IC50=0.011 µM). Batoprotafib has the potential for the study of RTK-dependent malignancies, especially advanced solid tumors .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-135103
CAS. Nr.: 145022-92-0
Reinheit:  98.60%
Synonyms: T-βMCA sodium
Target:  

FXR

Forschungsgebiete:  

Cancer

Tauro-β-muricholic Acid sodium (T-βMCA sodium), a endogenous metabolite, is a competitive and reversible farnesoid X receptor (FXR) antagonist, with an IC50 of 40 μM .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-N2146
CAS. Nr.: 117048-59-6
Synonyms: CRC 87-09
Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin with Kd of 0.4 μM.
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-N2187
CAS. Nr.: 43043-74-9
Deoxyshikonin increases the expression of VEGF-C and VEGF-A mRNA in HMVEC-dLy, promotes HIF-1α and HIF-1β subunit interaction and binds to specific DNA sequences targeted by HIF. Deoxyshikonin inhibited colorectal cancer (CRC) through the PI3K/Akt/mTOR pathway. Deoxyshikonin has proangiogenesis effect and antitumor activity. Deoxyshikonin is an antibacterial agent against methicillin-resistant S. aureus (MRSA) and S. pneumonia (MIC=17 μg/mL) .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-139611
CAS. Nr.: 2630904-45-7
Reinheit:  99.40%
Synonyms: MRTX-1719; BMS-986504
Forschungsgebiete:  

Cancer

Navlimetostat is a potent, orally active, selective PRMT5-MTA complex inhibitor, with IC50 of 3.6 and 20.5 nM for PRMT5-MTA and PRMT5. Navlimetostat binds to the PRMT5-MTA complex, with KD value of 0.14 pM. Navlimetostat shows antineoplastic activity in vitro and in vivo, and can be used for cancer study .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-B1414
CAS. Nr.: 88-04-0
Synonyms: p-Chloro-m-xylenol; PCMX
Chloroxylenol is a broad-spectrum antibacterial agent that can be used to control bacteria, algae, fungi and viruses .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-120675
CAS. Nr.: 1242422-09-8
Reinheit:  99.37%
Target:  

Casein Kinase Wnt

Forschungsgebiete:  

Cancer

SSTC3 is a casein kinase 1α (CK1α) activator (Kd = 32 nM) that inhibits WNT signaling (EC50 = 30 nM). SSTC3 exhibits minimal gastrointestinal toxicity compared to other classes of WNT inhibitors .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-136541
CAS. Nr.: 1144043-83-3
Reinheit:  99.80%
Synonyms: Wnt pathway inhibitor 2
Target:  

Wnt Apoptosis

Forschungsgebiete:  

Cancer

YB-0158 (Wnt pathway inhibitor 2) is a reverse-turn peptidomimetic and a potent colorectal cancer stem cell (CSC) targeting agent. YB-0158 disrupts Sam68-Src interactions and induces apoptosis in CRC cells. Anti-cancer activities .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-B1324
CAS. Nr.: 64211-46-7
Synonyms: Ro 13-8996
Forschungsgebiete:  

Infection Cancer

Oxiconazole (Ro 13-8996) nitrate is a broad spectrum anti-fungal agent which can inhibit the growth of Candida, Aspergillus and Trichophyton. Oxiconazole nitrate is also a highly efficacious activator of CYP3A4 transactivation, which could be antagonized by Rifampicin (HY-B0272) in a competitive manner. Oxiconazole nitrate exhibits inhibitory effect against colorectal cancer (CRC) via peroxiredoxin-2 (PRDX2)-mediated autophagy arrest .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-N3389
CAS. Nr.: 66056-19-7
Licoisoflavone A is an orally active isoflavone. Licoisoflavone A inhibits proliferation, induces apoptosis, and causes G1/S phase arrest in colorectal cancer (CRC) cells. Licoisoflavone A inhibits the CDK2-Cyclin E1 axis. Licoisoflavone A inhibits lipid peroxidation with an IC50 of 7.2 μM. Licoisoflavone A shows a dose-dependent inhibition effect on SARS-CoV-2 infection. Licoisoflavone A exhibits significant anti-tumor efficacy in mice bearing CT26 cell subcutaneous xenografts. Licoisoflavone A can be used for the study of colorectal cancer and SARS-CoV-2 infection .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-B0008
CAS. Nr.: 38194-50-2
Synonyms: MK-231
Target:  

NF-κB PD-1/PD-L1

Forschungsgebiete:  

Inflammation/Immunology Cancer

Sulindac (MK-231) is an orally active nonsteroidal anti-inflammatory agent. Sulindac also is an immunomodulatory agent. Sulindac can be used for the research of arthritis of the spine, gouty arthritis and kinds of cancer including colorectal cancer (CRC) and lung cancer .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-120852
CAS. Nr.: 1464910-32-4
Reinheit:  98.14%
JG26 is an ADAM inhibitor with IC50 values of 12 nM, 1.9 nM, and 150 nM for ADAM8, ADAM17, and ADAM10, respectively. JG26 inhibits MMP-12 with an IC50 value of 9.4 nM. JG26 inhibits AngII (HY-13948)-induced EGFR transactivation and ERK activation. JG26 increases the expression of ACE2, inhibits the cleavage of CD23, reduces the infection of SARS-CoV-2. JG26 inhibits colorectal cancer metastasis. JG26 can be used for research on Hodgkin lymphoma and vascular diseases .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-107460
CAS. Nr.: 1198408-78-4
Reinheit:  ≥99.0%
Target:  

Ephrin Receptor

Forschungsgebiete:  

Cancer

LDN-211904 oxalate is a potent and reversible EphB3 inhibitor with an IC50 of 79 nM. LDN-211904 oxalate shows good metabolic stability in mouse liver microsomes. LDN-211904 oxalate with Cetuximab (HY-P9905) could be effective in inhibiting STAT3-activated colorectal cancer (CRC) stemness and Cetuximab resistance in CRC .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P1201
CAS. Nr.: 84211-54-1
Target:  

Somatostatin Receptor

Forschungsgebiete:  

Cancer

Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist. Cyclosomatostatin can inhibit somatostatin receptor type 1 (SSTR1) signaling and decreases cell proliferation, ALDH+ cell population size and sphere-formation in colorectal cancer (CRC) cells .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-123772
CAS. Nr.: 865317-30-2
Reinheit:  99.62%
Synonyms: CP668863
Target:  

CDK

Forschungsgebiete:  

Cancer

CDK5 inhibitor 20-223 is a potent CDK2 and CDK5 inhibitor with IC50s of 6.0 and 8.8 nM, respectively. CDK5 inhibitor 20-223 is an effective anti-colorectal cancer (CRC) agent .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-153833
CAS. Nr.: 2904682-19-3
Reinheit:  99.77%
Synonyms: KVA-E-23A
Target:  

Gap Junction Protein

Forschungsgebiete:  

Cancer

PDS-0330 is a specific and potent Claudin-1 inhibitor. PDS-0330 interferes with claudin-1/Src association and inhibits colorectal cancer (CRC) progression and metastasis .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P6083
CAS. Nr.: 1995062-44-6
Forschungsgebiete:  

Others Cancer

RTSPSSR is synthesized peptide, which binds specifically to claudin-1 and visulizes the CRC tumor in mice, through near-infrared fluorescence imaging .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-N3001
CAS. Nr.: 957-66-4
Isolinderalactone is a sesquiterpene that exhibits anti-cancer, anti-inflammatory, and neuroprotective effects. Isolinderalactone inhibits VEGF expression and tyrosine phosphorylation of VEGFR2. Isolinderalactone decreases viability and induces apoptosis in U-87 glioblastoma (GBM) cells and colorectal cancer (CRC) cells. Isolinderalactone induces G2/M phase cell cycle arrest, ROS generation, pJNK/p38 MAPK activation, in colorectal cancer (CRC) cells. Isolinderalactone blocks LPS (HY-D1056)-induced NF-κB activation while activating Nrf2-HMOX1 signaling in RAW264.7 macrophages. Isolinderalactone improves cognitive dysfunction in APP/PS1 mice. Isolinderalactone can be used for the study of Glioblastoma multiforme (GBM), colorectal cancer, Alzheimer’s disease and acute lung injury .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-Q51222
CAS. Nr.: 100264-64-0
Forschungsgebiete:  

Cancer

ZINC110492 is a selective ligand of CS-ΔEx4 (a splicing isoform of citrate synthase (CS)). ZINC110492 does not bind to CS full-length (CS-FL). ZINC110492 inhibits colorectal cancer (CRC) cell growth in cells overexpressing CS-ΔEx4 with an IC50 of 7.840 µM. ZINC110492 significantly decreases both citrate and 2-hydroxyglutarate (2-HG) levels in the CS-ΔEx4-overexpressing SW1116 cells .
loading...
    loading...